Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
2(50%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
25%
Ph phase_1
2
50%
Ph phase_3
1
25%

Phase Distribution

2

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(2)

Detailed Status

Recruiting2
Completed2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (50.0%)
Phase 21 (25.0%)
Phase 31 (25.0%)

Trials by Status

recruiting250%
completed250%

Recent Activity

2 active trials
Showing 4 of 4
recruitingphase_3

A Study of HDM1005 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone

NCT07394114
completedphase_1

Phase Ia Clinical Study of HDM1005 Injection

NCT06640647
completedphase_1

Phase Ib Clinical Study of HDM1005 Injection

NCT06637020
recruitingphase_2

Phase II Clinical Study of HDM1005 Injection in Obese Adults Without Diabetes Mellitus

NCT06886126

Clinical Trials (4)

Showing 4 of 4 trials
NCT07394114Phase 3

A Study of HDM1005 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone

Recruiting
NCT06640647Phase 1

Phase Ia Clinical Study of HDM1005 Injection

Completed
NCT06637020Phase 1

Phase Ib Clinical Study of HDM1005 Injection

Completed
NCT06886126Phase 2

Phase II Clinical Study of HDM1005 Injection in Obese Adults Without Diabetes Mellitus

Recruiting

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4